Skip to main content

Tang Capital Partners LP

No open-market purchases or sales filed in the past year.

Current role at each company

Show 2 more companies

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Tang Capital Partners LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

OMIC Singular Genomics Systems, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2024 (view filing)4:31 PM ETSep 16-182 daysTang Kevin C and 2 others10% OwnerPPurchase+122.4K$14.75+$1.81M+49.0%372.0K after3 lots

Rain Oncology Inc.

10% Owner3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 18, 2023 (view filing)6:29 PM ETDec 14-184 daysTang Kevin C and 2 others10% OwnerSSale−174.0K$1.20−$209.4K−4.3%3.85M after3 lots
Oct 13, 2023 (view filing)4:57 PM ETOct 11-132 daysTang Kevin C and 2 others10% OwnerPPurchase+284.1K$0.982+$279.0K+7.6%4.02M after5 lots
Jun 1, 2023 (view filing)6:46 PM ETMay 30-Jun 12 daysTang Kevin C and 2 others10% OwnerPPurchase+1.09M$1.06+$1.16M+41.0%3.74M after9 lots

TCRR TCR2 Therapeutics Inc.

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 30, 2023 (view filing)8:02 PM ETMay 255 daysTang Kevin C and 2 others10% OwnerPPurchase+50.0K$1.72+$86.0K+1.2%4.39M after
May 15, 2023 (view filing)5:12 PM ETMay 11-124 daysTang Kevin C and 2 others10% OwnerPPurchase+44.9K$1.95+$87.6K+1.0%4.34M after2 lots
May 10, 2023 (view filing)7:02 PM ETMay 8-102 daysTang Kevin C and 2 others10% OwnerPPurchase+84.0K$1.95+$163.8K+2.0%4.30M after3 lots
May 5, 2023 (view filing)6:52 PM ETMay 3-52 daysTang Kevin C and 2 others10% OwnerPPurchase+289.6K$1.89+$547.9K+7.4%4.22M after4 lots

JNCE Jounce Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 14, 2023 (view filing)8:39 PM ETMar 13-141 dayTang Kevin C and 2 others10% OwnerPPurchase+86.0K$0.9997+$86.0K+1.6%5.30M after2 lots

LJPC La Jolla Pharmaceutical Co

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 1, 2021 (view filing)7:07 PM ETNov 29-Dec 12 daysTang Kevin C and 3 othersDirector, 10% OwnerSSale−441.3K$3.93−$1.73M−4.4%9.61M after5 lots

APVO Aptevo Therapeutics Inc.

Other: Exit Filing2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 26, 2021 (view filing)1:02 PM ETNov 233 daysTang Kevin C and 2 othersOther: Exit FilingSSale−921.3K$11.25−$10.4M−100.0%0 after7 lots
Nov 22, 2021 (view filing)5:26 PM ETNov 18-224 daysTang Kevin C and 2 others10% OwnerSSale−838.7K$7.75−$6.50M−47.7%921.3K after10 lots

ODT Odonate Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 19, 2021 (view filing)4:38 PM ETNov 17-192 daysTang Kevin C and 3 othersChief Executive OfficerSSale−2.75M$2.09−$5.73M−17.7%12.8M after8 lots